Physician

Rattandeep Singh, MD

According to 2025 Medicare claims, Rattandeep Singh, MD (NPI: 1174536478) practices rheumatology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Fulton, GA. Singh uses personal NPI as billing NPI and primary practice location at 30305-2372. Singh is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 129,101 HCPCS/CPT codes, and received $3,103,191 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,561 prescription claims across 461 beneficiaries totaling $1,786,264 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 202 records totaling $4,300. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $80,886 to $3,103,191. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $615,130 to $1,786,264. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	327	1,769	$80,886
2016	353	1,920	$93,808
2017	331	5,215	$140,429
2018	339	27,283	$709,908
2019	352	52,697	$1,063,666
2020	333	66,918	$1,581,007
2021	374	76,601	$1,892,239
2022	387	81,483	$2,058,454
2023	441	107,441	$1,928,541
2024	435	129,101	$3,103,191

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	361	3,771	$615,130
2016	396	4,224	$752,507
2017	396	4,382	$1,183,244
2018	387	3,641	$983,462
2019	374	3,189	$791,548
2020	375	3,001	$674,852
2021	400	3,035	$1,063,466
2022	456	3,120	$1,496,870
2023	455	3,131	$1,796,583
2024	461	2,561	$1,786,264

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	64	72	$146
96413	Administration of chemotherapy into vein, 1 hour or less	86	642	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	347	740	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	73	88	$71
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	99	125	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	38	1,372	$307,287
Humira(Cf) Pen	Adalimumab	36	1,008	$264,885
Tremfya	Guselkumab	11	616	$148,657
Taltz Syringe	Ixekizumab	11	308	$147,988
Rinvoq	Upadacitinib	18	540	$113,599

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	202	$4,300	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Rheumatology providers in the Atlanta-Sandy Springs-Roswell, GA market
Providers within practice ZIP code 30305-2372
Providers whose plurality patient county is Fulton, GA
Providers in Georgia affiliated with Mission Health Partners, LLC (MSSP)

FAQ

What Medicare data is available for Rattandeep Singh, MD?

Tedicare shows public-source Medicare data for Rattandeep Singh, MD (NPI 1174536478), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rattandeep Singh, MD have ACO affiliation data?

Rattandeep Singh, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Rattandeep Singh, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Rattandeep Singh, MD have Open Payments data?

Rattandeep Singh, MD has 202 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.